A Fabry Disease Gene Therapy Study

Clinical trial NCT04040049 · TERMINATED

Trial details

NCT number: NCT04040049
Sponsor: Spur Therapeutics
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Fabry Disease Lysosomal Storage Diseases

Start date: 2019-07-08
Primary completion: 2023-05-02
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.